Falcon Capital Acquisition Corp. (FCAC) Shareholders Approve Sharecare Deal
by Marlena Haddad on 2021-06-29 at 5:43pm

Falcon Capital Acquisition Corp.  (NASDAQ:FCAC) announced in a press release  as well as in an 8-K filing today that its shareholders approved its combination with digital healthcare firm Sharecare at a special meeting held today.

The press release and 8-K did not mention redemptions, but noted that more than 97% of the votes cast, or 32,080,366 votes, at the meeting were in favor of the approval of the business combination. Investors reacted well to the news as FCAC rose 6.70% in post-market trading following the announcement.

Falcon shareholders also voted overwhelmingly to approve the other proposals which included to amend and restate the amended and restated certificate of incorporation to include a certificate of designations for the Series A Preferred Stock, change the name to Sharecare, Inc. and increase the authorized number of shares to 615,000,000. Additionally, shareholders approved the proposal to issue certain securities and the new incentive plan.

The transaction is expected to close on Thursday, July 1 and the combined company’s stock and warrants will start trading on the Nasdaq under the new symbols “SHCR” and “SHCRW”, respectively, on Friday, July 2.

Falcon Capital announced the $3.9 billion deal with Sharecare on February 12. Sharecare provides a patient-communication and digital health platform to insurers and healthcare providers.

For a full list of proposals and vote tallies, click HERE.


ADVISORS

  • Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC acted as financial advisors to Sharecare
  • King & Spalding LLP acted as legal counsel to Sharecare
  • Goldman Sachs Group acted as financial advisor to Falcon Capital Acquisition Corp
  • White & Case LLP acted as legal counsel to Falcon Capital Acquisition Corp
  • Goldman Sachs and J.P. Morgan Securities LLC acted as joint placement agents in connection with the PIPE offering
Recent Posts
by Nicholas Alan Clayton on 2024-04-23 at 4:05pm

Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...

by Nicholas Alan Clayton on 2024-04-23 at 7:50am

At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...

by Nicholas Alan Clayton on 2024-04-22 at 3:01pm

With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...

by Nicholas Alan Clayton on 2024-04-22 at 7:51am

At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...

by Kristi Marvin on 2024-04-20 at 11:45am

Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved